article thumbnail

EFPIA states AI rules must “enable not hinder” pharma R&D

Drug Discovery World

The area of medicines development is already a highly regulated space in Europe EFPIA believes that these existing EU legal frameworks, in addition to other regulatory frameworks and policies for medicines set standards to ensure a high level of public health protection.

article thumbnail

Despite COVID-19, pharma R&D funding at all-time high: IQVIA

Outsourcing Pharma

According to the clinical research solutions firm, disruptions due to the pandemic did not stop the industry from fueling R&D at unprecedented levels.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharma R&D investment report shows positive signs: Deloitte

Outsourcing Pharma

According to the companyâs 12th Annual Pharmaceutical Innovation Report, pharmaceutical R&D return on investment has climbed to its highest peak since 2014.

article thumbnail

Innovation in insulin delivery: Two companies look to transform diabetes treatment

BioPharma Reporter

Multiple pharma R&D teams are seeking to transform how diabetes treatment is managed.